Home Archive
Archive
2025 Volume 46 Issue 2  Published: 2025-02-10
    Recommendation
  • Hongbo LI , Ying YANG , Yongfeng YU , Shun LU
    doi: 10.13683/j.wph.2025.02.001

    The clinical use of targeted agents has revolutionized treatment strategies for non-small cell lung cancer(NSCLC) patients carrying targetable mutations for two decades, and has resulted in significant survival benefits. In recent years, the types and clinical use of targeted agents have expanded, with breakthroughs in the treatment of advanced to locally advanced unresectable patients and perioperative adjuvant treatment of resectable patients. In advanced patients, the combination of targeted drugs with chemotherapy or dual-antibody drugs has also provided new options for first-line and subsequent treatment. Meanwhile, antibody-drug conjugates have made positive progress in the subsequent treatment of advanced patients. This article aimed to review the research progress of targeted drugs in the clinical application of intermediate and advanced NSCLC.

  • Topic
  • Yujie FU , Xihui CHEN , Minyu LIU
    doi: 10.13683/j.wph.2025.02.002

    Non-alcoholic steatohepatitis(NASH), as a chronic metabolic disease, is closely related to obesity, diabetes mellitus type 2, hyperlipidemia and other metabolic syndromes. Its pathogenesis involves multiple factors such as genetics, environment and lifestyle, especially metabolic disorders as the core driving force, which promote disease progression through oxidative stress, endoplasmic reticulum stress and inflammatory pathway activation. For the treatment of NASH, multiple potential therapeutic targets have been identified, such as metabolic regulation, blocking of inflammatory pathways, and anti-fibrosis. NASH may also progress to severe diseases such as cirrhosis and liver cancer, which poses a major threat to human health. In addition, NASH is often accompanied by other metabolic diseases, forming a vicious cycle that further increases the difficulty of treatment and the burden on patients. This article aims to comprehensively review the pathogenesis, therapeutic targets and drug research progress of NASH, and discuss its harm to humans, so as to provide reference for future research and clinical practice.

  • Topic
  • Yanyan ZENG , Zhilong LAN , Yingbo LI , Shan JIANG , Na NI , Junlong WANG
    doi: 10.13683/j.wph.2025.02.003

    Metabolic associated steatohepatitis(MASH), formerly known as non-alcoholic steatohepatitis. If the disease is not controlled, it can lead to cirrhosis and liver cancer. With the continuous development of the discipline, the diagnosis and treatment of MASH have made great progress. However, because of its complex mechanism of action, many clinical trials have failed even after entering phase Ⅲ. This aritcle focused on the metabolic disorder of MASH, and summarized the double/triple receptor agonists targeting the metabolism of glucagon peptide-1 receptor and other incretin signaling pathways, so as to provide certain references for the better development of MASH treatment and the design of related clinical trials.

  • Topic
  • Rui CHEN , Xueying LIU , Huihui SHI , Haowen WANG , Wenqi HUANG , Tao YANG
    doi: 10.13683/j.wph.2025.02.004

    Fatty liver is a disease characterized by abnormal accumulation of fat in liver cells, the incidence of which is increasing year by year, and has become an urgent public health problem in the world. The pathogenesis of fatty liver is complex, including alcoholic and non-alcoholic factors, metabolic disorders and drug effects. In recent years, traditional Chinese medicine and its active ingredients have been widely concerned by researchers because of their unique multi-target characteristics and overall conditioning effects. This article reviewed the research progress of some Chinese herbal compounds and their effective components in the treatment of non-alcoholic fatty liver disease.

  • Article
  • Linli ZHANG , Lan WANG , Li LIU
    doi: 10.13683/j.wph.2025.02.005
    Objective

    To investigate the effects of lipopolysaccharide(LPS) on organoid growth, stem cells and related pathways.

    Methods

    The intestinal crypts of C57BL/6J mice were aseptically isolated and collected in vitro, and the three-dimensional small intestinal organoids with multi-bud structure were cultured. Immunofluorescence staining was used to identify the cell composition of small intestinal organoids. After passage, small intestinal organoids were randomly divided into control group(LPS 0 μg/ml) and different concentrations of LPS groups(30、100 and 300 μg/ml). The growth and morphological characteristics of organoids, and the changes of stem cells and proliferating cells induced by LPS were observed. Comparative RNA sequencing and bioinformatics analysis were used to characterize the changes in genes and pathways induced by LPS.

    Results

    In D6 culture, small intestinal crypts formed stereoscopic intestinal organoids with multiple budding structures accompanying the intestinal lumen. After modeling, LPS inhibited the formation of intestinal organoid sprout structure, and the area of intestinal organoids was significantly reduced in a dose-dependent manner. IF staining results showed that the expression of intestinal cells and proliferating cells was increased. The comparative RNA sequencing showed that the expression of stem cells and proliferation-related genes was significantly increased, and the stem cells pathway was enriched.

    Conclusion

    The LPS-induced intestinal organoid injury model was initially constructed in vitro, and the mechanism and pathway of stem cell enhancement after injury were revealed, providing a reliable research platform for the mechanism research of intestinal diseases and the screening of effective drugs.

  • Article
  • Kanghua ZHU , Xia LI , Hang DONG , Qun JIANG , Tianhua CHEN , Zi LI
    doi: 10.13683/j.wph.2025.02.006
    Objective

    To investigate the function and mechanism of trigonelline on radicular pain in rat model of lumbar disc herniation(LDH).

    Method

    The LDH rat model was established by autologous nucleus pulposus transplantation. Western blot was used to detect the expression levels of ionized calcium-binding adapter protein(Iba)-1 in microglia and glial fibrillary acidic protein(GFAP) and Toll-like receptor(TLR)4/NOD-like receptor protein(NLRP)3 related pathway proteins in astrocytes. Enzyme-linked immunosorbent assay was used to detect the levels of inflammatory factors and pain factors in serum.

    Results

    Compared with the control group, the levels of interleukin and tumor necrosis factor-α in the model group were significantly increased(P<0.01). Compared with the model group, the levels of interleukin and tumor necrosis factor-α in trigonelline group were significantly decreased(P<0.05). Compared with the control group, the levels of neuropeptide Y and serotonin in the model group increased significantly(P<0.01). Compared with model group, the levels of neuropeptide Y and 5-hydroxytryptamine in fenugreek group were significantly decreased(P<0.05), and high dose fenugreek group was significantly better than low dose group(P<0.05). Compared with the control group, the expression levels of Iba-1 and GFAP in model group were significantly up-regulated(P<0.01). Compared with model group, the expressions of Iba-1 and GFAP in trigonelline group were significantly decreased(P<0.05) in a dose-dependent manner(P<0.05). Compared with the control group, the protein expression levels of TLR4 and NLRP3 in model group were significantly increased(P<0.05), while the protein expression levels of TLR4 and NLRP3 in trigonelline group were significantly decreased(P<0.05), and the inhibitory effect of high-dose trigonelline group was more significant(P<0.05).

    Conclusion

    Trigonelline inhibits radicular pain in LDH rats by modulating TLR4/NLRP3 pathway.

  • Article
  • Meifang ZHANG , Xiaoli LI , Gang XUE , Jun LYU
    doi: 10.13683/j.wph.2025.02.007
    Objective

    To investigate the effects of Guaxie Xiangdan recipe combined with bisoprolol on total ischemic burden(TIB) and serum resistin level in patients with stable angina pectoris(SAP).

    Methods

    A total of 150 SAP patients admitted to our hospital from June 2021 to June 2023 were randomly grouped into the Western medicine group(n=75, treated with bisoprolol) and the combination group(n=75, treated with Guaxie Xiangdan recipe+bisoprolol). The therapeutic efficacy, cardiac function indicators, TIB, serum resistin levels and occurrence of adverse reactions were compared between the two groups.

    Results

    The effective rate of the combination group was higher than that of the Western medicine group, and the difference was statistically significant(P<0.05). After treatment, the left ventricular ejection fraction, and early mitral valve diastolic peak blood flow/late mitral valve diastolic peak blood flow increased in both groups compared to before treatment, and the combination group was higher than the Western medicine group(P<0.05). The levels of TIB and serum resistin in both groups decreased compared to before treatment, and the combination group was lower than the Western medicine group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(8.00% vs. 14.67%, P>0.05).

    Conclusion

    Guaixie Xiangdan recipe combined with bisoprolol can effectively improve the cardiac function of SAP patients, reduce the level of TIB and serum resistin, and has good application safety.

  • Article
  • Huiying ZHAO , Shengyu MA , Yun YANG , Xuexue LI
    doi: 10.13683/j.wph.2025.02.008
    Objective

    To observe the efficacy of high-dose dexamethasone(DXM) combined with rafutrombopag in the treatment of newly diagnosed primary immunologic thrombocytopenic purpura(ITP).

    Methods

    A total of 80 newly diagnosed primary ITP patients in our hospital from June 2020 to June 2023 were enrolled and divided into control group(high-dose DXM) and study group(high-dose DXM+rafutrombopag) by district randomization method, with 40 cases in each group. Platelet count(PLT) levels, the distribution of T lymphocyte subsets, efficacy and the occurrence of adverse reactions were compared between the two groups before treatment and at D7, D14, D30 and D60 of treatment.

    Results

    At D7, D14, D30 and D60 of treatment, the PLT levels in both groups were higher than before(P<0.05), and the PLT levels of the study group were higher than those in the control group at D7, D14 and D30(P<0.05). After treatment, cluster of differentiation(CD)3+, CD4+, CD4+/CD8+, complement C3, complement C4 and interleukin(IL)-4 in both groups were increased compared with those before treatment(P<0.05), and the study group was higher than the control group(P<0.05). The levels of CD8+, IL-2, IL-10 and interferon in both groups were lower than before treatment(P<0.05), and the study group was lower than the control group(P<0.05). The total effective rate of the study group was higher than that of the control group(85.00% vs. 65.00%, P<0.05), the rate of DXM secondary administration(10.00% vs. 30.00%, P<0.05) and the incidence of adverse reactions(25.00% vs. 52.50%, P<0.05) were lower than those of the control group.

    Conclusion

    High-dose DXM combined with rafutrombopag in the treatment of newly diagnosed primary ITP can effectively up-regulate PLT level, improve the distribution of T lymphocyte subsets, improve efficacy, and reduce the rate of DXM secondary administration and the incidence of adverse reactions.

  • Article
  • Haiyan TIAN , Lili WEI , Ruwei QIN
    doi: 10.13683/j.wph.2025.02.009
    Objective

    To investigate the therapeutic effect of idebenone combined with dopamine on Parkinson's disease(PD) and its effects on serum neurocytokines and oxidative stress indexes.

    Methods

    A total of 130 PD patients in our hospital from June 2022 to December 2023 were selected and divided into observation group and control group according to simple ordering random method, with 65 cases in each group. On the basis of conventional treatment, the control group was treated with levodopa and benserazide hydrochloride tablets, and the observation group was treated with idebenone on the treatment regimen of the control group. The course of treatment of both groups was 3 months. The clinical efficacy, the unified PD rating scale(MDS-UPDRS)Ⅲ, non-motor symptoms scale(NMSS), mini mental status examination(MMSE) score, and nerve growth factor(NGF), brain-derived neurotrophic factor(BDNF), malondialdehyde(MDA), superoxide dismutase(SOD), glutathione peroxidase(GSH-Px) and catalase(CAT) were compared between the two groups.

    Results

    The overall response rate of observation group was higher than that of control group (84.62% vs. 67.69%, P<0.05). The MDS-UPDRS III, NMSS score and serum MDA level in the observation group were lower than those in the control group(P<0.05). The MMSE score, serum NGF, BDNF, SOD, GSH-Px and CAT levels in observation group were higher than those in control group(P<0.05).

    Conclusion

    Idebenone combined with dopamine is effective in the treatment of PD, which can improve the symptoms and cognitive function of patients, and its mechanism may be related to the regulation of serum neurocytokines and oxidative stress response.

  • Article
  • Saiting SHI , Jianmei YANG , ge ZHANG , Xiangqian XU , Xiaoyu XU
    doi: 10.13683/j.wph.2025.02.010
    Objective

    To observe the effect of medicated cupping on stable chronic obstructive pulmonary disease(COPD) patients with lung and kidney deficiency syndrome.

    Methods

    A total of 66 patients with stable COPD in the outpatient and ward of Respiratory Department of our hospital from January 2022 to January 2024 were selected and divided into experimental group and control group according to the simple sorting random method, with 33 cases in each group. The experimental group was treated with Sanziqi Bai decoction combined with cupping treatment at the acupoints of Dazhui, Dingchuan, Gaomang, Feishu, Shenshu and Zusanli, while the control group was given simple cupping treatment on Mondays and Thursdays, twice a week for 8 weeks. This study mainly observed the changes of forced expiratory volume in one second(FEV1)/forced vital capacity(FVC). The secondary outcome measures included peak expiratory flow, percentage of predicted value of FEV1 (FEV1%), percentage of predicted value of FVC(FVC%), and C-reactive protein, tumor necrosis factor(TNF)-α, COPD assessment test(CAT), 6-minute walk test (6MWT) and the change of traditional Chinese medicine(TCM) syndrome score.

    Results

    After treatment, the FEV1/FVC of the patients in the experimental group was higher than that of the control group, and the TCM syndrome score was lower(P<0.05). Compared with before treatment, the FEV1%, FVC% and 6MWT of experimental group were increased, while TNF-α, CAT score and TCM syndrome score were decreased(P<0.05), the therapeutic effect of experimental group was better than that of control group(P<0.05).

    Conclusions

    Medicated cupping is effective in treating stable COPD patients with lung-kidney deficiency, effectively improving lung function, TCM syndrome score, reducing inflammation and improving quality of life.

  • Article
  • Yanci LI , Jianfang LIU , Yanping ZHANG , Xiaojiao WANG , Xia ZHENG , Yao MENG
    doi: 10.13683/j.wph.2025.02.011
  • Review
  • Bing HU , Lili GONG , Liang PENG , Haojun ZHANG , Hankun HU , Lihong LIU
    doi: 10.13683/j.wph.2025.02.012

    The BXD recombinant inbred mouse strains, developed through the hybridization of female C57BL/6J and male DBA/2J mice, followed by over 20 generations of brother-sister matings, represent the largest and most genetically characterized group of recombinant inbred strain populations of mammals globally, with over 150 strains. These mice exhibit significant genetic diversity and extensive phenotypic variation, alongside a wealth of genotype, phenotype, and omics data. These characteristics make BXD mice a valuable resource for studying complex traits and diseases, which can be used for the construction of disease models, the study of disease mechanisms, drug target discovery, and preclinical drug evaluation. The application of BXD mice is crucial in advancing biomedical research, promoting disease prevention and treatment, and achieving precision medicine. With the deepening of research, BXD mice are poised to play a greater role across various fields.

  • Review
  • Xingyue FAN , Yaqin HOU , Xu JIA
    doi: 10.13683/j.wph.2025.02.013

    Intracranial infections caused by multidrug-resistant Gram-negative bacteria is a difficult problem in clinical treatment. Tigecycline, a novel antibiotic, has demonstrated potential against multidrug-resistant Gram-negative bacteria and has become an important option for treating intracranial infections. This article reviewed the research progress of tigecycline in treating intracranial infections, including its antimicrobial mechanism, pharmacokinetic characteristics, and therapeutic efficacy. It also pointed out that the safety of tigecycline treatment needed further verification. It was recommended to minimize the potential risks of tigecycline in the treatment for intracranial infections, balance the efficacy and safety, and achieve optimal treatment through individualized treatment plans, combination therapy, pharmaceutical monitoring and evaluation in clinical practice.

  • Review
  • Luyao LI , Sha WANG , Xiangdong YANG
    doi: 10.13683/j.wph.2025.02.014

    Autoimmune disease(AID) is a class of diseases characterized by excessive inflammatory response to autoantigens, B lymphocytes are the core of the pathogenesis of AID, and cluster of differentiation(CD)20 monoclonal antibodies targeting at B lymphocytes depletion are widely used in the treatment of AID. Obinutuzumab, a type Ⅱhumanized anti-CD20 monoclonal antibody, can significantly reduce the number of B lymphocytes and inhibit the production of autoantibodies, and can be used to treat AID. This article reviewed the application progress of obinutuzumab in AID, aiming to provide some reference for clinical use.

  • Review
  • Wenxin XU , Qiuyue GUO , Xu HAN , Qingguang CHEN , Hao LU , Mengjie CAI
    doi: 10.13683/j.wph.2025.02.015

    Pancreatic fat deposition can impair the function of islet β cells and is closely related to the occurrence and development of type 2 diabetes mellitus(T2DM). Therefore, reducing pancreatic fat deposition is an important step to promote the remission of T2DM. Traditional Chinese medicine(TCM) believes that pancreatic fat deposition is related to the abnormal function of spleen transportation and metabolism, and Chinese herbal compounds with the effect of invigorating spleen and qi can reduce pancreatic fat deposition. This article systematically reviewed the relationship between pancreatic fat deposition and the pathogenesis of T2DM, and the improvement effect of TCM on it, in order to provide new directions and ideas for the treatment of T2DM with TCM and western medicine treatment.

News